• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童神经病学中新的抗癫痫药物更新:儿科癫痫治疗进展。

Update on the newer antiepileptic drugs in child neurology: advances in treatment of pediatric epilepsy.

机构信息

James J. Riviello, Jr, MD Section of Neurology and Developmental Neuroscience, Baylor College of Medicine; Texas Children’s Hospital, 6621 Fannin, CC 1250, Houston, TX 77030, USA.

出版信息

Curr Treat Options Neurol. 2007 Nov;9(6):395-403. doi: 10.1007/s11940-007-0041-2.

DOI:10.1007/s11940-007-0041-2
PMID:18173939
Abstract

The goal of epilepsy treatment is the prevention of recurrent seizures, and antiepileptic drugs (AEDs) are the mainstay. Uncontrolled seizures may cause medical, developmental, and psychologic disturbances. Treatment advances include 1) identification of the basic mechanisms of epilepsy and action of AEDs, 2) the introduction of many new AEDs, and 3) the use of neurostimulation, starting with vagus nerve stimulation. We must balance the efficacy of an AED versus its side effects, which if persistent, lead to patient discontinuation of the AED. Although all AEDs have a proven efficacy, they are differentiated by their efficacy for a given seizure type or epilepsy syndrome versus the side effects or tolerability. The many new AEDs give us a larger armamentarium for epilepsy treatment. We refer to studies and expert opinion consensus.

摘要

癫痫治疗的目标是预防反复发作,抗癫痫药物(AEDs)是主要手段。未得到控制的癫痫发作可能导致医学、发育和心理问题。治疗进展包括:1)确定癫痫和 AED 作用的基本机制,2)引入许多新的 AED,3)开始使用神经刺激,首先是迷走神经刺激。我们必须平衡 AED 的疗效与其副作用,因为如果副作用持续存在,患者将停止使用 AED。尽管所有 AED 都有已证实的疗效,但它们在特定的癫痫发作类型或癫痫综合征的疗效方面有所不同,而与副作用或耐受性有关。许多新的 AED 为我们提供了更多的癫痫治疗手段。我们参考研究和专家意见共识。

相似文献

1
Update on the newer antiepileptic drugs in child neurology: advances in treatment of pediatric epilepsy.儿童神经病学中新的抗癫痫药物更新:儿科癫痫治疗进展。
Curr Treat Options Neurol. 2007 Nov;9(6):395-403. doi: 10.1007/s11940-007-0041-2.
2
Newer anticonvulsant medications in pediatric neurology.儿科神经病学中的新型抗惊厥药物。
Curr Treat Options Neurol. 2010 Nov;12(6):518-28. doi: 10.1007/s11940-010-0094-5.
3
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.
4
Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.美国癫痫治疗现状:抗癫痫药物——Connectors 项目简介。
Epilepsy Behav. 2018 Mar;80:98-103. doi: 10.1016/j.yebeh.2017.12.026. Epub 2018 Feb 2.
5
Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.癫痫缓解期患者早期与晚期停用抗癫痫药物的比较。
Cochrane Database Syst Rev. 2015 Feb 11;2015(2):CD001902. doi: 10.1002/14651858.CD001902.pub2.
6
Update on Antiepileptic Drugs 2019.2019年抗癫痫药物最新进展
Continuum (Minneap Minn). 2019 Apr;25(2):508-536. doi: 10.1212/CON.0000000000000715.
7
Rapid versus slow withdrawal of antiepileptic drugs.抗癫痫药物的快速撤药与缓慢撤药
Cochrane Database Syst Rev. 2006 Apr 19(2):CD005003. doi: 10.1002/14651858.CD005003.pub2.
8
Antiepileptic drugs for seizure control in people with neurocysticercosis.用于控制神经囊尾蚴病患者癫痫发作的抗癫痫药物。
Cochrane Database Syst Rev. 2015 Oct 12(10):CD009027. doi: 10.1002/14651858.CD009027.pub2.
9
Antiepileptic Drug Treatment of Epilepsy in Children.儿童癫痫的抗癫痫药物治疗
Continuum (Minneap Minn). 2019 Apr;25(2):381-407. doi: 10.1212/CON.0000000000000712.
10
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.新诊断癫痫患者使用现有和新型抗癫痫药物治疗的治疗结局:一项长达 30 年的纵向队列研究。
JAMA Neurol. 2018 Mar 1;75(3):279-286. doi: 10.1001/jamaneurol.2017.3949.

引用本文的文献

1
Newer anticonvulsant medications in pediatric neurology.儿科神经病学中的新型抗惊厥药物。
Curr Treat Options Neurol. 2010 Nov;12(6):518-28. doi: 10.1007/s11940-010-0094-5.

本文引用的文献

1
Use of the newer antiepileptic drugs in pediatric epilepsies.新型抗癫痫药物在儿科癫痫中的应用。
Curr Treat Options Neurol. 2007 Jul;9(4):256-67. doi: 10.1007/s11940-007-0012-7.
2
Long-term use of zonisamide in refractory childhood-onset epilepsy.唑尼沙胺在儿童难治性癫痫中的长期应用。
Eur J Paediatr Neurol. 2008 Jan;12(1):19-23. doi: 10.1016/j.ejpn.2007.05.003. Epub 2007 Jun 18.
3
Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.左乙拉西坦在儿童重症癫痫患者中的长期应用。
Eur J Paediatr Neurol. 2007 Nov;11(6):341-5. doi: 10.1016/j.ejpn.2007.02.016. Epub 2007 Apr 17.
4
Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.左乙拉西坦对4岁以下儿童的疗效和耐受性:一项回顾性研究。
Epilepsia. 2007 Jun;48(6):1123-7. doi: 10.1111/j.1528-1167.2007.01003.x.
5
Safety of rapid intravenous valproate infusion in pediatric patients.小儿患者快速静脉输注丙戊酸盐的安全性。
Pediatr Neurol. 2007 Feb;36(2):81-3. doi: 10.1016/j.pediatrneurol.2006.11.003.
6
Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.左乙拉西坦单药治疗儿童和青少年良性罗兰多癫痫发作
Seizure. 2007 Apr;16(3):271-5. doi: 10.1016/j.seizure.2006.12.006. Epub 2007 Jan 3.
7
Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy.氯巴占作为难治性局灶性癫痫儿童附加疗法的有效性。
Arq Neuropsiquiatr. 2006 Sep;64(3B):705-10. doi: 10.1590/s0004-282x2006000500001.
8
Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.儿童和青少年的奥卡西平单药治疗:单中心临床经验
Pediatr Neurol. 2006 Oct;35(4):235-9. doi: 10.1016/j.pediatrneurol.2006.02.009.
9
Felbamate: consensus of current clinical experience.非氨酯:当前临床经验共识
Epilepsy Res. 2006 Oct;71(2-3):89-101. doi: 10.1016/j.eplepsyres.2006.06.020. Epub 2006 Aug 4.
10
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.国际抗癫痫联盟治疗指南:抗癫痫药物作为癫痫发作和综合征初始单药治疗的疗效和有效性的循证分析
Epilepsia. 2006 Jul;47(7):1094-120. doi: 10.1111/j.1528-1167.2006.00585.x.